CSL gets contract to increase US stockpile for bird flu vaccines to 40 million doses

(Reuters) - Australia's CSL (OTC:CSLLY ) said on Wednesday it has got a contract from the U.S. Department of Health and Human Services (HHS) worth $121.4 million to increase the U.S. government's stockpile for bird flu vaccines to 40 million doses.

Under the contract CSL will deliver its MF59 adjuvant, an ingredient that can be used to manufacture vaccines against the A(H5) avian influenza virus.

The funding is part of a partnership with the Biomedical Advanced Research and Development Authority (BARDA).



A part of HHS, the BARDA helps companies develop medical supplies to address public health threats.

This is the fifth award CSL has received from the BARDA in response to the bird flu outbreak. Under its previous contract it delivered about 4.8 million doses of the vaccine.

Source: Investing.com